<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">94056</article-id>
<article-id pub-id-type="doi">10.7554/eLife.94056</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.94056.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology and Inflammation</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Self-inhibiting percolation and viral spreading in epithelial tissue</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0464-4562</contrib-id>
<name>
<surname>Xu</surname>
<given-names>Xiaochan</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3868-9187</contrib-id>
<name>
<surname>Nielsen</surname>
<given-names>Bjarke Frost</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9820-3567</contrib-id>
<name>
<surname>Sneppen</surname>
<given-names>Kim</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Niels Bohr Institute, University of Copenhagen</institution>, 2100 Copenhagen, <country>Denmark</country></aff>
<aff id="a2"><label>2</label><institution>PandemiX Center, Department of Science and Environment, Roskilde University</institution>, 4000 Roskilde, <country>Denmark</country></aff>
<aff id="a3"><label>3</label><institution>Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, University of Copenhagen</institution>, 2200 Copenhagen Ø, <country>Denmark</country></aff>
<aff id="a4"><label>4</label><institution>High Meadows Environmental Institute, Princeton University</institution>, Princeton, New Jersey 08544, <country>USA</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Ispolatov</surname>
<given-names>Yaroslav</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Santiago Chile</institution>
</institution-wrap>
<city>Santiago</city>
<country>Chile</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Schoggins</surname>
<given-names>John W</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>The University of Texas Southwestern Medical Center</institution>
</institution-wrap>
<city>Dallas</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label><bold>For correspondence:</bold> <email>sneppen@nbi.ku.dk</email> (KS)</corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-01-24">
<day>24</day>
<month>01</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP94056</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-11-23">
<day>23</day>
<month>11</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-12-13">
<day>13</day>
<month>12</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.12.12.571279"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Xu et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Xu et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-94056-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>SARS-CoV-2 induces delayed type-I/III interferon production, allowing it to escape the early innate immune response. The delay has been attributed to a deficiency in the ability of cells to sense viral replication upon infection, which in turn hampers activation of the antiviral state in bystander cells. Here, we introduce a cellular automaton model to investigate the spatiotemporal spreading of viral infection as a function of virus and host-dependent parameters. The model suggests that the considerable person-to-person heterogeneity in SARS-CoV-2 infections is a consequence of high sensitivity to slight variations in biological parameters near a critical threshold. It further suggests that within-host viral proliferation can be curtailed by the presence of remarkably few cells that are primed for IFN production. Thus the observed heterogeneity in defense readiness of cells reflects a remarkably cost-efficient strategy for protection.</p>
</abstract>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Adaptive immune responses are relatively slow since they require pathogen-specific priming of immune cells (<bold><italic><xref ref-type="bibr" rid="c33">Sette and Crotty, 2021</xref></italic></bold>). For example, the time required for the body to activate adaptive immunity against the SARS-CoV-2 virus upon initial infection is around 10 days, comparable to the delay of immunization against SARS-CoV-2 after vaccination (<bold><italic><xref ref-type="bibr" rid="c28">Polack et al., 2020</xref></italic></bold>). Instead, the earliest infection dynamics are largely governed locally, by infected cells and their neighborhood. The innate responses including both interferon (IFN) mediated intercellular communication and expression of antiviral genes (ISGs) are determinants for confining the viral spread in the respiratory tract. Here, we address the spread of viruses within epithelial tissue, using SARS-CoV-2 as a model pathogen. The overall considerations are similar for other viruses, but the parameters governing infection may vary considerably due to the specific countermeasures of the virus in question, affecting its ability to bypass human antiviral defenses.</p>
<p>In terms of countermeasures, insufficient type I and III interferon secretion upon infection is a main immune signature feature of SARS-CoV-2 infection (<bold><italic><xref ref-type="bibr" rid="c4">Blanco-Melo et al., 2020</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c15">Hatton et al., 2021</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c34">Stanifer et al., 2020</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c25">Minkoff and tenOever, 2023</xref></italic></bold>). The failure to activate immediate antiviral responses with IFNs is also a pathogenic aspect of other viruses including Ebola (<bold><italic><xref ref-type="bibr" rid="c26">Mohamadzadeh et al., 2007</xref></italic></bold>), Marburg (<bold><italic><xref ref-type="bibr" rid="c16">He et al., 2019</xref></italic></bold>) and Herpes simplex (<bold><italic><xref ref-type="bibr" rid="c2">Barreca and O’Hare, 2004</xref></italic></bold>). Secretion of IFN relies on the cell’s ability to sense viral products during its replication. Despite the presence of sensors for DNA and RNA viruses in cells, many species of viruses partially evade detection. The SARS-CoV-2 virus is such a case: Only two of 16 putative RNA virus sensors, IFIH1 (MDA5) and DHX58 (LGP2) from the RIG-I-like receptor (RLR) family, play roles in inducing IFN upon SARS-CoV-2 infection (<bold><italic><xref ref-type="bibr" rid="c41">Yin et al., 2021</xref></italic></bold>) and IFIH1 is antagonized by SARS-CoV-2 (<bold><italic><xref ref-type="bibr" rid="c21">Liu et al., 2021</xref></italic></bold>).</p>
<p>Intriguingly, evidence shows that pre-activated innate immune states help combat the SARS-CoV-2 infection. The higher basal expression of viral sensors, IFIH1 and DDX58 (also from the RLR family), in the upper airway of children (relative to adults), reduces the severity of COVID (<bold><italic><xref ref-type="bibr" rid="c22">Loske et al., 2022</xref></italic></bold>). Furthermore, well-differentiated primary nasal epithelial cells derived from a donor with pre-activated IFN<sub><italic>γ</italic></sub> do show resistance to SARS-CoV-2 infection (<bold><italic><xref ref-type="bibr" rid="c5">Broadbent et al., 2022</xref></italic></bold>). Thus, the extent to which innate immunity contributes to the observed heterogeneity in responses to SARS-CoV-2 between hosts (<bold><italic><xref ref-type="bibr" rid="c31">Schaller et al., 2021</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c10">Desai et al., 2020</xref></italic></bold>) is a compelling subject for investigation.</p>
<p>To address this question, we reanalyze single-cell RNAseq data (<bold><italic><xref ref-type="bibr" rid="c11">Fiege et al., 2021</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c29">Ravindra et al., 2021</xref></italic></bold>) providing gene expression profiles of virus sensors and antiviral genes in host cells during early SARS-CoV-2 infection. We propose a cellular automaton model based on a few transition rules suggested by observed cell states, to explain the heterogeneity in early disease progression as a consequence of criticality in the virus-host interaction system.</p>
<sec id="s1a">
<title>Cell states during infection</title>
<p>Directly observing cell responses and cell state transitions in a patient’s body upon viral infection is virtually impossible. However, human bronchial epithelial cells (HBECs) mimic the airway epithelium and have been used as a representative model for investigating the consequences of the viral invasion (<bold><italic><xref ref-type="bibr" rid="c9">de Jong et al., 1993</xref>, <xref ref-type="bibr" rid="c8">1994</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c7">Davis et al., 2015</xref></italic></bold>). Single-cell RNAseq provides snapshots of the states of individual cells indicated by high-dimensional gene expression profiles at the mRNA level and can uncover the heterogeneity of cell responses obscured by aggregate measurement. Thus, by combining HBECs as a model and single-cell RNAseq data, one can in principle infer cell state transitions following viral infection. More importantly, single-cell RNAseq also captures copies of viral genes during sequencing, which allows us to simultaneously estimate viral replication inside cells.</p>
<p>To reconstruct the trajectory of cell state transitions during early SARS-CoV-2 infection, we re-analyze single-cell RNAseq data from experiments where HBECs are sampled before infection (0 h), as well as 24 and 48 hours post-viral infection (hpi) (<bold><italic><xref ref-type="bibr" rid="c11">Fiege et al., 2021</xref></italic></bold>). We focus on genes associated with antiviral responses and interferons from the host cells and detected viral genes. We project high-dimensional gene expression data onto a 2D plane using Uniform Manifold Approximation and Projection (UMAP) and obtain a low-dimensional visualization of single-cell expression patterns (<xref rid="fig1" ref-type="fig">Fig. 1a</xref>). On the UMAP plane, each dot represents a cell sample and the distance between dots correlates with the level of similarity of cellular states. The cells are not divided absolutely into discrete clusters and rather show continuous trajectories. For simplicity and convenience, we cluster the cells according to their gene expression.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1.</label>
<caption><p>Cell states during SARS-CoV-2 infection in human tracheal/bronchial epithelial cells. <bold>a)</bold> 6162 cells (<bold><italic><xref ref-type="bibr" rid="c11">Fiege et al., 2021</xref></italic></bold>) covering samples of mock-infected (0 h), 24 hpi (hours post-infection), and 48 hpi visualized with UMAP. <bold>b)</bold> Average expression of representative viral genes, IFNs, and antiviral genes with each cell cluster (state). <bold>c)</bold> Cell proportions of clusters at different time points (hpi = 0, 24, and 48). Cell proportions are labeled with corresponding colors in <bold>a). d)</bold> Average expression (0–48h) of antiviral genes (IFIT1, IFIT2, IFIT3, IFIT5, IFIH1, OAS1, OAS2, OAS3, OASL, DDX58). <bold>e)</bold> Average expression (0–48h) of viral genes (cov.orf1ab, cov.S, cov.orf3a, cov.orf6, cov.M, cov.N). <bold>f)</bold> Average expression (0–48h) of interferon genes (IFNB1, IFNL1, IFNL2,IFNL3). 103 cells (1.7%) are IFN-positive. <bold>g)</bold> Progression of viral infection as indicated by changes in cell proportions of different states. Cells are shown separately at each time point in the leftmost column. The right columns show the average expression of antiviral genes, viral genes, and IFNs in the corresponding cells.</p></caption>
<graphic xlink:href="571279v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Different clusters on the UMAP indicate distinct cellular states during the progression of infection. For instance, there are three sub-clusters of susceptible cells (<italic>O</italic><sub>1</sub>, <italic>O</italic><sub>2</sub>, <italic>O</italic><sub>3</sub>). Neither viral genes nor IFNs are detected in these cells and only a few antiviral genes are expressed. The viral sensors (DHX58, DDX58, and IFIH1) are at their lowest level (<xref rid="fig1" ref-type="fig">Fig. 1b</xref>, Fig. S1). We refer to all of these cells as <italic>O</italic> cells due to their relatively similar gene expression profiles in terms of viral replication genes. The proportion of <italic>O</italic> cells decreases over time as the infection spreads (<xref rid="fig1" ref-type="fig">Fig. 1c</xref>).</p>
<p>We also observe three infected cell clusters where viral genes are primarily detected, <italic>V</italic> <sup><italic>i</italic></sup>, <italic>V</italic> <sup><italic>r</italic></sup>, and <italic>V</italic> . With the increasing counts of viral genes, we infer that the <italic>V</italic> <sup><italic>i</italic></sup> cluster is the earliest state after an <italic>O</italic> cell has been infected and the virus begins to replicate. Some but not all antiviral genes are activated in the <italic>V</italic> <sup><italic>i</italic></sup> cells (IFIT1/2/3 and OAS1/2/3) (<xref rid="fig1" ref-type="fig">Fig. 1b</xref> and Fig. S1), indicating that these cells are still vulnerable to viral invasion. This cluster is followed by two subsequent clusters, the <italic>V</italic> <sup><italic>r</italic></sup> cluster with pronounced viral replication and <italic>A</italic> cluster with barely any viral replication.</p>
<p>In the <italic>V</italic> cluster, the viral genes reach their highest level and antiviral genes are strongly inhibited, indicating that the virus has fully hijacked the cell. The antiviral genes are expressed most strongly in the <italic>A</italic> cluster and partially in the <italic>N</italic> cluster, indicating that the antiviral capability of the <italic>N</italic> cluster is weaker than the full antiviral state. Although the <italic>N</italic> cluster also shows a high level of viral genes, it severely lacks one of the viral genes (cov.E, Fig. S2) compared with the most highly expressed viral genes of the <italic>V</italic> cluster. This observation implies that viral replication and activation of the antiviral state coexist in the IFN-secreting cells (<italic>N</italic> cluster). We note the existence of a small subgroup of the <italic>V</italic> <sup><italic>r</italic></sup> cluster, close to the <italic>A</italic> cluster, that exhibits relatively high levels of both antiviral genes and viral genes but no appreciable IFN (<xref rid="fig1" ref-type="fig">Fig. 1d–f</xref>). The viral genes are also partially expressed in these cells, but different from the <italic>N</italic> cluster, the antiviral genes are fully expressed (Fig. S1 and S2). Thus, these cells are more likely to sustain the antiviral state.</p>
<p>At 24 hpi, some cells have switched from the pre-infection state (<italic>O</italic>) to other states. At 48 hpi, almost all cells have transitioned to other states and only a few cells remain in the <italic>O</italic> state (<xref rid="fig1" ref-type="fig">Fig. 1c</xref> and <xref ref-type="fig" rid="fig1">g</xref>). The aggregated gene expression of representative antiviral genes and detected viral genes indicates the cells move from the <italic>O</italic> state towards the three remaining terminal states on the considered timescale of 2 days: Antiviral state (<italic>A</italic>, <xref rid="fig1" ref-type="fig">Fig. 1d</xref>), Virus-conquered state (<italic>V</italic>, <xref rid="fig1" ref-type="fig">Fig. 1e</xref>), and IFN producing state (<italic>N</italic>, <xref rid="fig1" ref-type="fig">Fig. 1f</xref>). Central for the overall defense is the relatively few cells that reach the IFN-producing state (<italic>N</italic> ). These cells also express <italic>A</italic> and <italic>V</italic> genes.</p>
<p>When IFN is not expressed, the antiviral genes and viral genes exclude each other (<xref rid="fig1" ref-type="fig">Fig. 1d</xref> and <xref ref-type="fig" rid="fig1">e</xref>), except for a few cells around (UMAP1, UMAP2) ∼ (−2.5, 7.5) (green cells at hpi = 48, <xref rid="fig1" ref-type="fig">Fig. 1g</xref>). They represent cells where the virus succeeded in stopping IFN secretion, but could not fully hijack the cell. We still regard these cells as antiviral cells in our model.</p>
<p>The <italic>N</italic> state is associated with both high levels of virus sensors and viral genes, in agreement with the observation that IFN production is initiated after exposure to the virus (<bold><italic><xref ref-type="bibr" rid="c20">Lei et al., 2020</xref></italic></bold>) and that IFN can induce an antiviral state inside the same cell (<bold><italic><xref ref-type="bibr" rid="c30">Sanceau et al., 1987</xref></italic></bold>). Expression of the key SARS-CoV-2 sensitive sensors (IFIH1, DDX58, DHX58) is sparse in the <italic>O</italic> state (Fig. S1), indicating that a small fraction of cells have virus-sensing capacity prior to infection and are ready to mount a defense – and that this population increases with IFN tissue diffusion.</p>
</sec>
<sec id="s1b">
<title>Model</title>
<p>We introduce a cellular automaton model to capture the cell state dynamics during early stages of SARS-CoV-2 infection in a sheet of epithelial tissue. At each simulation, we seed an infection site on a 2D square lattice and study how the infection spreads as the sites on the lattice switch between cell states following a set of simple rules derived from the observations of the single-cell RNAseq data.</p>
<p>In addition to the states corresponding to the dominant clusters observed in the single-cell data (<xref rid="fig1" ref-type="fig">Fig. 1a</xref>) (<italic>O, A, V</italic> and <italic>N</italic> states corresponding to <italic>O, A, V</italic> and <italic>N</italic> clusters), we introduce a transient pre-antiviral state (<italic>a</italic>) that can switch to the <italic>N</italic> state rapidly on viral exposure, considering the heterogeneity of viral sensing ability in susceptible cells.</p>
<p>It follows from this description, that those RNA viruses that can sensed by a large repertoire of sensors should be modeled with a larger fraction of cells in the <italic>a</italic> state.</p>
<p>The model is initialized with cells predominantly in the <italic>O</italic> state and a small fraction, <italic>P</italic><sub><italic>a</italic></sub>, in the pre-antiviral state <italic>a</italic>. The parameter <italic>P</italic><sub><italic>a</italic></sub> can also be understood as the probability that an <italic>O</italic> cell will switch to the <italic>N</italic> or <italic>A</italic> state when exposed to the virus or IFNs, respectively. As such, the value of <italic>P</italic><sub><italic>a</italic></sub> depends on both host and virus. In particular, a virus that is able to effectively interfere with the defense and signaling of host cells will be modeled by a low <italic>P</italic><sub><italic>a</italic></sub> value.</p>
<p>It is worth noting that the proportion of cells in the <italic>a</italic> state before the onset of SARS-CoV-2 infection is expected to be higher in hosts with pre-activated antiviral innate immunity (<bold><italic><xref ref-type="bibr" rid="c22">Loske et al., 2022</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c5">Broadbent et al., 2022</xref></italic></bold>), meaning that the value of <italic>P</italic><sub><italic>a</italic></sub> will, in general, depend on the exposure history of the host.</p>
<p>We propose the following transitions between five main discrete cell states (<xref rid="fig2" ref-type="fig">Fig. 2a</xref>):</p>
<list list-type="bullet">
<list-item><p><italic>N</italic>, IFN-secreting cells. These arise from pre-antiviral cells (<italic>a</italic> state) that become infected (but not infectious). Here we ignore possible apoptosis (<bold><italic><xref ref-type="bibr" rid="c39">Wen et al., 1997</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c37">Tesfaigzi, 2006</xref></italic></bold>) of <italic>N</italic> cells since IFNs still have time to diffuse to the neighborhood.</p></list-item>
<list-item><p><italic>O</italic>, unaffected (susceptible) cells.</p></list-item>
<list-item><p><italic>V</italic>, infected cells, virus-producing cells. This state arises when a susceptible (<italic>O</italic>) cell is exposed to a virus from another <italic>V</italic> cell.</p></list-item>
<list-item><p><italic>a</italic>, pre-antiviral state. May develop into either the <italic>A</italic> or <italic>N</italic> state upon exposure to signals from <italic>N</italic> cells or virus from <italic>V</italic> cells.</p></list-item>
<list-item><p><italic>A</italic>, antiviral state. Immune to infection. Achieved when a pre-antiviral (<italic>a</italic>) cell is exposed to IFN. We do not consider the decay of the antiviral state as it may last more than 72 h (<bold><italic><xref ref-type="bibr" rid="c12">Gaajetaan et al., 2013</xref></italic></bold>).</p></list-item>
</list>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2.</label>
<caption><p>NOVAa model. <bold>a)</bold> The cell state transitions are included in the NOVAa model. The simpler OVA model bypasses the <italic>a</italic> and <italic>N</italic> states, by allowing <italic>V</italic> to induce direct <italic>O</italic> → <italic>A</italic> transitions (Fig. S3). <bold>b)</bold> Final states of a small lattice (50 × 50) simulations at two different values of <italic>P</italic><sub><italic>a</italic></sub> (both at IFN spreading radius <italic>R</italic> = 1). <bold>c)</bold> The fraction of cells in each state in the final frozen configuration as a function of <italic>P</italic><sub><italic>a</italic></sub>. A critical transition is observed at <italic>P</italic><sub><italic>a</italic></sub> = <italic>P</italic><sub><italic>c</italic></sub> ∼ 27.8%. At lower values of <italic>P</italic><sub><italic>a</italic></sub>, most cells terminate in the <italic>V</italic> state, representing an aggressive tissue infection. Simulations were performed on a lattice with linear dimension <italic>L</italic> = 1000.</p></caption>
<graphic xlink:href="571279v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The dynamics are defined in terms of discrete time steps, representing the characteristic timescales of cellular viral infection. We explore the model for an extended time, keeping in mind that in reality other immune cells such as NK-killer cells and macrophages may migrate to the infected site and reduce viral spread (<bold><italic><xref ref-type="bibr" rid="c23">McNab et al., 2015</xref></italic></bold>).</p>
<p>The four rules of the model are (<xref rid="fig2" ref-type="fig">Fig. 2a</xref>):
<disp-formula id="ueqn1">
<graphic xlink:href="571279v1_ueqn1.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
where the notation <italic>X</italic>(<italic>Y</italic> ) = <italic>Z</italic> denotes a cell in state <italic>X</italic> acting on a cell in state <italic>Y</italic> and changing it to state <italic>Z</italic> in one time-step. Thus, cells in states <italic>O, a</italic>, and <italic>A</italic> are unable to influence their neighbors. The <italic>V</italic> state is the only directly self-replicating state.</p>
<p>Each site of the <italic>L</italic> × <italic>L</italic> lattice is assigned to either the <italic>O</italic> (probability: 1 − <italic>P</italic><sub><italic>a</italic></sub>) or the <italic>a</italic> state (probability: <italic>P</italic><sub><italic>a</italic></sub>). Infection is initiated by a single <italic>V</italic> cell, and we explore the percolation of the infection to larger scales. A time step consists of <italic>L</italic><sup>2</sup> updates, in which a random site <italic>i</italic> is selected. If a <italic>V</italic> cell is selected, it interacts with its 4 nearest neighbors according to the rules <italic>V</italic> (<italic>O</italic>) = <italic>V</italic> and <italic>V</italic> (<italic>a</italic>) = <italic>N</italic> . If an <italic>N</italic> cell is selected, it interacts with all cells within a radius <italic>R</italic>, according to the rules <italic>N</italic> (<italic>O</italic>) = <italic>a</italic> and <italic>N</italic> (<italic>a</italic>) = <italic>A</italic>. The radius <italic>R</italic> thus quantifies the diffusion range of IFNs relative to the virus.</p>
</sec>
</sec>
<sec id="s2">
<title>Results</title>
<p>At <italic>R</italic> = 1, the final number of infected cells depends strongly on the value of <italic>P</italic><sub><italic>a</italic></sub>. At a low <italic>P</italic><sub><italic>a</italic></sub> of 0.27, infections typically spread to the entire system, while at a higher <italic>P</italic><sub><italic>a</italic></sub> of 0.35, the propagation of the <italic>V</italic> state is inhibited (<xref rid="fig2" ref-type="fig">Fig. 2b</xref>).</p>
<p>We observe a threshold-like behavior of the final attack rate of the virus when the initial <italic>P</italic><sub><italic>a</italic></sub> changes continuously (<xref rid="fig2" ref-type="fig">Fig 2c</xref>). The virus spreads macroscopically for <italic>P</italic><sub><italic>a</italic></sub> <italic>&lt; P</italic><sub><italic>c</italic></sub> ≈ 27.8%. At higher <italic>P</italic><sub><italic>a</italic></sub>, cells are sufficiently prone to convert to the antiviral state to prevent the infection from percolating.</p>
<p>The size distribution <italic>P</italic> (<italic>s</italic>) of infection clusters around the critical value of <italic>P</italic><sub><italic>a</italic></sub> = 27.8% obeys power-law decay (<xref rid="fig3" ref-type="fig">Fig. 3a</xref>). In <xref rid="fig3" ref-type="fig">Fig. 3b</xref>, the distribution <italic>P</italic> (<italic>s</italic>) ∝ 1/<italic>s</italic><sup><italic>τ</italic></sup> is further explored by re-scaling and the cluster size exponent is confirmed as <italic>τ</italic> = 1.83 ± 0.03 when <italic>P</italic><sub><italic>a</italic></sub> = 28%. Notably, this exponent is below the equilibrium 2D percolation yielding <italic>τ</italic> = 2.05 (<bold><italic><xref ref-type="bibr" rid="c35">Stauffer and Aharony, 2018</xref></italic></bold>). Further, our exponent <italic>τ</italic> ∼ 1.8 is above to the percolation-inspired cluster growth model for virus spread of ref. (<bold><italic><xref ref-type="bibr" rid="c13">Gönci et al., 2010</xref></italic></bold>) which has an exponent between <italic>τ</italic> = 1.58 and <italic>τ</italic> = 1.64 depending on the distribution of individual cells’ pre-defined ability to become infected.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3.</label>
<caption><p>Cluster size distribution. <bold>a)</bold> The distribution of infected cells (<italic>s</italic> = (<italic>N</italic> + <italic>V</italic> )/<italic>L</italic><sup>2</sup>) for different values of <italic>P</italic><sub><italic>a</italic></sub>, simulated by starting with one infected cell in a 2D square lattice of linear extent <italic>L</italic> = 2000. <bold>b)</bold> The exponents from a) are extracted by re-scaling as shown on the <italic>y</italic>-axis, yielding <italic>τ</italic> = 1.83. The cut-off exponent is estimated as <italic>σ</italic> ∼ 1. Simulations plot the final outbreak sizes from 10,000 initial infections of one cell. The histogram is log-binned with 5 bins per decade. The critical point at <italic>P</italic><sub><italic>a</italic></sub> = <italic>P</italic><sub><italic>c</italic></sub> = 0.28 is determined as the value with the longest scaling regime.</p></caption>
<graphic xlink:href="571279v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The actual critical value of <italic>P</italic><sub><italic>a</italic></sub> depends strongly on the choice of neighborhood. In particular, at <italic>R</italic> = 1, the <italic>V</italic> and <italic>N</italic> states have the same range in the tissue (a proxy for diffusivity), while a more realistic scenario is to allow IFNs to diffuse faster in the tissue (<italic>R &gt;</italic> 1), facilitating the initiation of the antiviral state. The critical percolation threshold <italic>P</italic><sub><italic>c</italic></sub> decreases almost exponentially with the value of <italic>R</italic> (<xref rid="fig4" ref-type="fig">Fig. 4b</xref>), and viral propagation can be stopped for <italic>P</italic><sub><italic>a</italic></sub> as low as 0.4% when <italic>R</italic> ≥ 5. Such a small fraction of initial cells in the <italic>a</italic> state is consistent with the remarkably few <italic>N</italic> cells observed in experiments (<xref rid="fig1" ref-type="fig">Fig. 1b</xref>). Thus, a higher diffusivity of IFN provides a more than proportional decrease in the required number of antiviral cells. As revealed by the reanalysis of RNAseq data in <xref rid="fig1" ref-type="fig">Fig. 1</xref>, the fraction of IFN-positive cells is relatively low – around 1.7%. Comparing with simulations near the critical point, we find that, at <italic>R</italic> = 5, the ratio of <italic>N</italic> cells to all affected cells (<italic>N</italic> + <italic>A</italic> + <italic>V</italic> ) in the final state, lim<sub><italic>t</italic>→∞</sub> <italic>N</italic> /(<italic>N</italic> + <italic>A</italic> + <italic>V</italic> ) ≈ 2%, i.e. it is of comparable magnitude to the experimental value. This holds in a wide range around the critical point, <italic>P</italic><sub><italic>a</italic></sub> ∼ <italic>P</italic><sub><italic>c</italic></sub>.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4.</label>
<caption><p>Range of IFN. <bold>a)</bold> Typical cluster for an <italic>R</italic> = 1 simulation at <italic>P</italic><sub><italic>a</italic></sub> ∼ <italic>P</italic><sub><italic>c</italic></sub> = 0.278. <bold>b)</bold> The dependence of <italic>P</italic><sub><italic>c</italic></sub> with <italic>R</italic>, approximately reproduced by a fit <italic>P</italic><sub><italic>c</italic></sub> ∼ 3<sup>−<italic>R</italic></sup>. For comparison the OVA model as well as percolation has <italic>P</italic><sub><italic>c</italic></sub> ∼ 3<sup>−<italic>R</italic>/2</sup>. In all cases, when <italic>P</italic><sub><italic>a</italic></sub> is above <italic>P</italic><sub><italic>c</italic></sub> then the virus is prevented from spreading. <bold>c)</bold> Cluster distribution for <italic>R</italic> = 5 at <italic>P</italic><sub><italic>a</italic></sub> ∼ <italic>P</italic><sub><italic>c</italic></sub> = 0.004, at a 5 times larger linear scale than a).</p></caption>
<graphic xlink:href="571279v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The exponents for the cluster size distribution are the same at <italic>R</italic> = 1 and <italic>R</italic> = 5, while the structures of the clusters are different (<xref rid="fig4" ref-type="fig">Fig. 4a</xref> and <xref rid="fig4" ref-type="fig">c</xref>). Greater <italic>R</italic> leads to a different microscopic structure with fewer <italic>A</italic> and <italic>N</italic> cells in the final state (<xref rid="fig4" ref-type="fig">Fig. 4c</xref>).</p>
<p>To put the above findings in perspective we further explore a simplified version of our model with only 3 states (supplementary Fig. S3), the OVA model, which may be seen as a rephrasing of models for induced antiviral states suggested by <bold><italic>Howat et al</italic></bold>. (<bold><italic>2006</italic></bold>); <bold><italic>Segredo-Otero and Sanjuán</italic></bold> (<bold><italic>2020</italic></bold>); <bold><italic>Michael Lavigne et al</italic></bold>. (<bold><italic>2021</italic></bold>). In the OVA model, <italic>P</italic><sub><italic>a</italic></sub> is the probability that an infected cell produces interferons to warn neighbor cells within radius <italic>R</italic>. In the OVA model, one update consists of selecting a random cell. If the cell is in the <italic>V</italic> state then its neighbor cells may change by exposure to the virus, provided that they are susceptible (<italic>O</italic>). Each of the four neighbors is now chosen in random order, and if a neighbor cell <italic>i</italic> is in the <italic>O</italic> state, a random number <italic>ran</italic><sub><italic>i</italic></sub> ∈ [0, 1] is drawn. If <italic>ran</italic><sub><italic>i</italic></sub> ≥ <italic>P</italic><sub><italic>a</italic></sub> the neighbor is flipped to the <italic>V</italic> state. If, on the other hand, <italic>ran</italic><sub><italic>i</italic></sub> <italic>&lt; P</italic><sub><italic>a</italic></sub>, all <italic>O</italic> cells within a radius <italic>R</italic> around the neighbor <italic>i</italic> are converted to the <italic>A</italic> state. Thus, for large <italic>R</italic> and moderate <italic>P</italic><sub><italic>a</italic></sub>, the spread of infection will be mitigated. We find that the OVA model has an “outbreak size” exponent <italic>τ</italic> ∼ 1.8, similar to the NOVAa model. However, the change in microstructure as a function of the IFN range <italic>R</italic> observed in the NOVAa model (compare <xref rid="fig4" ref-type="fig">Fig. 4</xref> panel a and c) is not observed in the OVA model (Fig. S3), where the features instead scale proportionally with <italic>R</italic>. We also simulated standard percolation by randomly adding disks of radius <italic>R</italic> of blocking (“antiviral”) cells and checking for percolation of the infected state. While the critical behavior of the standard percolation model approximately resembles that of the OVA model (<xref rid="fig4" ref-type="fig">Fig. 4b</xref>), the antiviral state of the OVA model is somewhat less effective at blocking the spread (reflected in a higher threshold <italic>P</italic><sub><italic>c</italic></sub>).</p>
<p>Finally, we examined a version of the model where the discrete idealization of <italic>N</italic> -cells acting at all cells within a specific radius <italic>R</italic> is replaced by a probabilistic conversion with a diffusion-like profile. The algorithm for this is described in the supplement, with results in Fig. S4 to be compared to <xref rid="fig4" ref-type="fig">Fig. 4</xref>. We find that the probabilistic spreading of IFN is more effective, in terms of demanding lower <italic>R</italic> for obtaining similar limits on spreading of the infection.</p>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>There are some preexisting models of the interplay between virus, host cells and triggered immune responses, with an antiviral state triggered by IFN signaling from neighbor cells (<bold><italic><xref ref-type="bibr" rid="c14">Graw and Perelson, 2016</xref></italic></bold>). Cellular automaton models of infection dynamics in epithelial tissue were explored by (<bold><italic><xref ref-type="bibr" rid="c17">Howat et al., 2006</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c32">Segredo-Otero and Sanjuán, 2020</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c24">Michael Lavigne et al., 2021</xref></italic></bold>), with the overall result that spreading depends on competition between the virus and an induced antiviral cell state. This competition is recapitulated in our model in terms of the two effective parameters <italic>P</italic><sub><italic>a</italic></sub> and <italic>R</italic>. Our model emphasizes the threshold dynamics, with a critical transition between effective confinement and unhindered spread that depends sensitively on the details of the relevant cell states. In particular, the presence of the specialized IFN-producing <italic>N</italic> cells allows for disease confinement at a much lower concentration of pre-antiviral cells (lower value of <italic>P</italic><sub><italic>a</italic></sub>) in the NOVAa model, than in the OVA model which lacks the <italic>N</italic> state (<xref rid="fig4" ref-type="fig">Fig. 4b</xref>). As a consequence of low <italic>P</italic><sub><italic>a</italic></sub>, the number of final <italic>N</italic> -state cells is also much lower.</p>
<p>The low concentration of ready-to-fight cells may seem perplexing, leading one to surmise that the organism could easily fight off an infection by only slightly increasing its investment in these primed cells. However, one should keep in mind that e.g. the human organism does indeed have ready-to-fight cells that are able to eliminate most foreign RNA, and only leave a few truly infectious viruses. As highlighted in the introduction, these select viruses often employ strategies to lower the <italic>P</italic><sub><italic>a</italic></sub>, for example by only being sensed by a small fraction of the RNA virus-sensitive receptors of our cells.</p>
<p>The parameter <italic>P</italic><sub><italic>a</italic></sub> can be interpreted as the probability that a cell is sufficiently antiviral to convert to a <italic>N</italic> state upon infection with a given virus. The relevant value of <italic>P</italic><sub><italic>a</italic></sub> will depend on the virus considered (and will be small for viruses that inhibit cell responses to infection) as well as on the host (e.g. on age (<bold><italic><xref ref-type="bibr" rid="c19">Kissler et al., 2020</xref></italic></bold>) and recent infection history). Dysregulated IFN responses are characteristic of the effective immunomodulatory strategies used by betacoronaviruses (<bold><italic><xref ref-type="bibr" rid="c6">Channappanavar et al., 2019</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c1">Acharya et al., 2020</xref></italic></bold>).</p>
<p>The parameter <italic>R</italic> reflects the signaling efficiency of an interferon-producing cell. Since <italic>R</italic> is measured in units of the typical distance that the virus spreads, it depends on viral properties, including its burst size, diffusion, and adsorption to host cells, with higher adsorption being associated with larger <italic>R</italic> values. For SARS-CoV-2 this suggests that lower ACE2 receptor counts would result in less adsorption to nearby cells, in turn allowing the virus to spread to more distant tissues (<bold><italic><xref ref-type="bibr" rid="c3">Bastolla, 2021</xref></italic></bold>) suggesting a lower value of <italic>R</italic>.</p>
<p>For viruses that do not delay the production of IFNs, <italic>P</italic><sub><italic>a</italic></sub> would be higher than for SARS-CoV-2, allowing neighbor cells around an infected site to form a kind of “ring vaccination” as the antiviral state dominates. In this sense, our model is consistent with the previous modeling of the roles of autocrine and paracrine interferon signaling suppression of viral infection (see e.g. (<bold><italic><xref ref-type="bibr" rid="c24">Michael Lavigne et al., 2021</xref></italic></bold>) for parallels between IFN response and ‘ring vaccination’).</p>
<p>We do not consider viral particles which enter the bloodstream and seed new infections non-locally. This may allow the virus to spread in the tissue at what would otherwise constitute sub-critical conditions in our model. Further, there may be tissue-specific variations in both <italic>P</italic><sub><italic>a</italic></sub> and <italic>R</italic>, adding larger-scale heterogeneity to the overall spreading. As the disease progresses one would expect additional heterogeneity to emerge, associated with variability in later host responses including macrophage activation and adaptive immunity (<bold><italic><xref ref-type="bibr" rid="c38">Wang et al., 2021</xref></italic></bold>).</p>
<p>The remarkable heterogeneity of disease progression in COVID-19, in the form of widely variable symptoms (<bold><italic><xref ref-type="bibr" rid="c36">Tabata et al., 2020</xref></italic></bold>) and transmission risk (<bold><italic><xref ref-type="bibr" rid="c27">Nielsen et al., 2021</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c18">Kirkegaard and Sneppen, 2021</xref></italic></bold>), has been widely observed. E.g. among university students, just 2% of SARS-CoV-2 positive hosts provided 90% of total respiratory viral load (<bold><italic><xref ref-type="bibr" rid="c40">Yang et al., 2021</xref></italic></bold>). In our formalism, we would understand such variability in terms of a <italic>P</italic><sub><italic>a</italic></sub> that is comparable to the critical value, but varying between hosts. A slight change of <italic>P</italic><sub><italic>a</italic></sub> then results in dramatic fluctuations in the outcome of an infection.</p>
<p>To be more quantitative, for SARS-CoV-2 the detected virus count on average grows by a factor of 3.5 (<bold><italic><xref ref-type="bibr" rid="c19">Kissler et al., 2020</xref></italic></bold>) in one infection generation of 8 hours (not to be confused with the between-host ‘generation time’ of the infection). This within-host reproductive number is far below the number of viruses produced from a cell, indicating severe restrictions from the innate immune system. On the other hand, 3.5 is still above the threshold for spreading, indicating that within-host amplification is super-critical. However, the measured amplification includes viruses that “jump” to other spots in an infected person, thereby suggesting a local spreading that is closer to the critical value than an amplification of 3.5 would suggest.</p>
<p>Our study finally compared the NOVAa model with the simpler OVA scenario that recapitulates earlier modeling of induced antiviral states (<bold><italic><xref ref-type="bibr" rid="c17">Howat et al., 2006</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c32">Segredo-Otero and Sanjuán, 2020</xref></italic></bold>; <bold><italic><xref ref-type="bibr" rid="c24">Michael Lavigne et al., 2021</xref></italic></bold>). These papers all build on a more homogeneous role of infected cells, each inducing some immunization of surrounding cells. Ref. (<bold><italic><xref ref-type="bibr" rid="c17">Howat et al., 2006</xref></italic></bold>) emphasizes the larger range of IFN signals compared to viral diffusion, while the focus of (<bold><italic><xref ref-type="bibr" rid="c32">Segredo-Otero and Sanjuán, 2020</xref></italic></bold>) is competition between viruses with different abilities to suppress IFN signaling. Ref. (<bold><italic><xref ref-type="bibr" rid="c24">Michael Lavigne et al., 2021</xref></italic></bold>) introduces a cellular automaton approach where the antiviral state leads to a type of ring vaccination that prevents the virus from spreading when more IFN is produced. Our OVA model may be seen as a simplified and more stochastic version of this last model. The NOVAa model then adds the additional benefits associated with the experimentally observed but low-abundance <italic>N</italic> state cells, which by their rarity adds to predicted randomness between the fate of individual infection centers during an early viral infection.</p>
</sec>
<sec id="d1e1484" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e1566">
<label>suplement</label>
<media xlink:href="supplements/571279_file02.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>BFN acknowledges financial support from the Carlsberg Foundation in the form of an Internationalisation Fellowship (grant no. CF23-0173) and through the Carlsberg Foundation’s Semper Ardens programme (grant no. CF20-0046), as well as from the Danish National Research Foundation (grant no. DNRF170). Novo Nordisk Foundation Center for Stem Cell Medicine is supported by Novo Nordisk Foundation grant NNF21CC0073729.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Acharya</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>G.</given-names></string-name>, and <string-name><surname>Gack</surname>, <given-names>M. U.</given-names></string-name> (<year>2020</year>). <article-title>Dysregulation of type i interferon responses in covid-19</article-title>. <source>Nature Reviews Immunology</source>, <volume>20</volume>(<issue>7</issue>):<fpage>397</fpage>–<lpage>398</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Barreca</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>O’Hare</surname>, <given-names>P.</given-names></string-name> (<year>2004</year>). <article-title>Suppression of herpes simplex virus 1 in mdbk cells via the interferon pathway</article-title>. <source>Journal of virology</source>, <volume>78</volume>(<issue>16</issue>):<fpage>8641</fpage>–<lpage>8653</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Bastolla</surname>, <given-names>U.</given-names></string-name> (<year>2021</year>). <article-title>Mathematical model of sars-cov-2 propagation versus ace2 fits covid-19 lethality across age and sex and predicts that of sars</article-title>. <source>Frontiers in Molecular Biosciences</source>, <volume>8</volume>:<fpage>706122</fpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Blanco-Melo</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Nilsson-Payant</surname>, <given-names>B. E.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>W.-C.</given-names></string-name>, <string-name><surname>Uhl</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hoagland</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Møller</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Jordan</surname>, <given-names>T. X.</given-names></string-name>, <string-name><surname>Oishi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Panis</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sachs</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>). <article-title>Imbalanced host response to sars-cov-2 drives development of covid-19</article-title>. <source>Cell</source>, <volume>181</volume>(<issue>5</issue>):<fpage>1036</fpage>–<lpage>1045</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Broadbent</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Bamford</surname>, <given-names>C. G.</given-names></string-name>, <string-name><surname>Lopez Campos</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Manzoor</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Courtney</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ali</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Touzelet</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>McCaughey</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Mills</surname>, <given-names>K.</given-names></string-name>, and <string-name><surname>Power</surname>, <given-names>U. F.</given-names></string-name> (<year>2022</year>). <article-title>An endogenously activated antiviral state restricts sars-cov-2 infection in differentiated primary airway epithelial cells</article-title>. <source>Plos one</source>, <volume>17</volume>(<issue>4</issue>):<fpage>e0266412</fpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Channappanavar</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Fehr</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wohlford-Lenane</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Abrahante</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Mack</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sompallae</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Mc-Cray</surname>, <given-names>P. B.</given-names></string-name>, <string-name><surname>Meyerholz</surname>, <given-names>D. K.</given-names></string-name>, <string-name><surname>Perlman</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal> (<year>2019</year>). <article-title>Ifn-i response timing relative to virus replication determines mers coronavirus infection outcomes</article-title>. <source>The Journal of clinical investigation</source>, <volume>129</volume>(<issue>9</issue>):<fpage>3625</fpage>–<lpage>3639</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Davis</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Chertow</surname>, <given-names>D. S.</given-names></string-name>, <string-name><surname>Moyer</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Suzich</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sandouk</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Dorward</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Logun</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Shelhamer</surname>, <given-names>J. H.</given-names></string-name>, and <string-name><surname>Taubenberger</surname>, <given-names>J. K.</given-names></string-name> (<year>2015</year>). <article-title>Validation of normal human bronchial epithelial cells as a model for influenza a infections in human distal trachea</article-title>. <source>Journal of Histochemistry &amp; Cytochemistry</source>, <volume>63</volume>(<issue>5</issue>):<fpage>312</fpage>–<lpage>328</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>de Jong</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>van Sterkenburg</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Hesseling</surname>, <given-names>S. C.</given-names></string-name>, <string-name><surname>Kempenaar</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Mulder</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Mommaas</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Dijkman</surname>, <given-names>J. H.</given-names></string-name>, and <string-name><surname>Ponec</surname>, <given-names>M.</given-names></string-name> (<year>1994</year>). <article-title>Ciliogenesis in human bronchial epithelial cells cultured at the air-liquid interface</article-title>. <source>American journal of respiratory cell and molecular biology</source>, <volume>10</volume>(<issue>3</issue>):<fpage>271</fpage>–<lpage>277</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>de Jong</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>van Sterkenburg</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Kempenaar</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Dijkman</surname>, <given-names>J. H.</given-names></string-name>, and <string-name><surname>Ponec</surname>, <given-names>M.</given-names></string-name> (<year>1993</year>). <article-title>Serial culturing of human bronchial epithelial cells derived from biopsies</article-title>. <source>In Vitro Cellular &amp; Developmental Biology-Animal</source>, <volume>29</volume>:<fpage>379</fpage>–<lpage>387</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Desai</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Neyaz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Szabolcs</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shih</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Thapar</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Nieman</surname>, <given-names>L. T.</given-names></string-name>, <string-name><surname>Solovyov</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Mehta</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lieb</surname>, <given-names>D. J.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>). <article-title>Temporal and spatial heterogeneity of host response to sars-cov-2 pulmonary infection</article-title>. <source>Nature communications</source>, <volume>11</volume>(<issue>1</issue>):<fpage>6319</fpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Fiege</surname>, <given-names>J. K.</given-names></string-name>, <string-name><surname>Thiede</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Nanda</surname>, <given-names>H. A.</given-names></string-name>, <string-name><surname>Matchett</surname>, <given-names>W. E.</given-names></string-name>, <string-name><surname>Moore</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Montanari</surname>, <given-names>N. R.</given-names></string-name>, <string-name><surname>Thielen</surname>, <given-names>B. K.</given-names></string-name>, <string-name><surname>Daniel</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Stanley</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Hunter</surname>, <given-names>R. C.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>). <article-title>Single cell resolution of sars-cov-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium</article-title>. <source>PLoS pathogens</source>, <volume>17</volume>(<issue>1</issue>):<fpage>e1009292</fpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Gaajetaan</surname>, <given-names>G. R.</given-names></string-name>, <string-name><surname>Geelen</surname>, <given-names>T. H.</given-names></string-name>, <string-name><surname>Vernooy</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Dentener</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Reynaert</surname>, <given-names>N. L.</given-names></string-name>, <string-name><surname>Rohde</surname>, <given-names>G. G.</given-names></string-name>, <string-name><surname>Beuken</surname>, <given-names>E. V.</given-names></string-name>, <string-name><surname>Grauls</surname>, <given-names>G. E.</given-names></string-name>, <string-name><surname>Bruggeman</surname>, <given-names>C. A.</given-names></string-name>, and <string-name><surname>Stassen</surname>, <given-names>F. R.</given-names></string-name> (<year>2013</year>). <article-title>Interferon-β induces a long-lasting antiviral state in human respiratory epithelial cells</article-title>. <source>Journal of Infection</source>, <volume>66</volume>(<issue>2</issue>):<fpage>163</fpage>–<lpage>169</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Gönci</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Németh</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Balogh</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Szabó</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Dénes</surname>, <given-names>Á.</given-names></string-name>, <string-name><surname>Környei</surname>, <given-names>Z.</given-names></string-name>, and <string-name><surname>Vicsek</surname>, <given-names>T.</given-names></string-name> (<year>2010</year>). <article-title>Viral epidemics in a cell culture: novel high resolution data and their interpretation by a percolation theory based model</article-title>. <source>PloS one</source>, <volume>5</volume>(<issue>12</issue>):<fpage>e15571</fpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Graw</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Perelson</surname>, <given-names>A. S.</given-names></string-name> (<year>2016</year>). <article-title>Modeling viral spread</article-title>. <source>Annual review of virology</source>, <volume>3</volume>:<fpage>555</fpage>–<lpage>572</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Hatton</surname>, <given-names>C. F.</given-names></string-name>, <string-name><surname>Botting</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Dueñas</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Haq</surname>, <given-names>I. J.</given-names></string-name>, <string-name><surname>Verdon</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Thompson</surname>, <given-names>B. J.</given-names></string-name>, <string-name><surname>Spegarova</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Gothe</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Stephenson</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Gardner</surname>, <given-names>A. I.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>). <article-title>Delayed induction of type i and iii interferons mediates nasal epithelial cell permissiveness to sars-cov-2</article-title>. <source>Nature Communications</source>, <volume>12</volume>(<issue>1</issue>):<fpage>7092</fpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="other"><string-name><surname>He</surname>, <given-names>F. B.</given-names></string-name>, <string-name><surname>Melén</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kakkola</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Julkunen</surname>, <given-names>I.</given-names></string-name> (<year>2019</year>). <article-title>Interaction of ebola virus with the innate immune system</article-title>. <source>Emerging Challenges in Filovirus Infections</source>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Howat</surname>, <given-names>T. J.</given-names></string-name>, <string-name><surname>Barreca</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>O’Hare</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Gog</surname>, <given-names>J. R.</given-names></string-name>, and <string-name><surname>Grenfell</surname>, <given-names>B. T.</given-names></string-name> (<year>2006</year>). <article-title>Modelling dynamics of the type i interferon response to in vitro viral infection</article-title>. <source>Journal of The Royal Society Interface</source>, <volume>3</volume>(<issue>10</issue>):<fpage>699</fpage>–<lpage>709</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Kirkegaard</surname>, <given-names>J. B.</given-names></string-name> and <string-name><surname>Sneppen</surname>, <given-names>K.</given-names></string-name> (<year>2021</year>). <article-title>Superspreading quantified from bursty epidemic trajectories</article-title>. <source>Scientific reports</source>, <volume>11</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="other"><string-name><surname>Kissler</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Fauver</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Mack</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Olesen</surname>, <given-names>S. W.</given-names></string-name>, <string-name><surname>Tai</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Shiue</surname>, <given-names>K. Y.</given-names></string-name>, <string-name><surname>Kalinich</surname>, <given-names>C. C.</given-names></string-name>, <string-name><surname>Jednak</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ott</surname>, <given-names>I. M.</given-names></string-name>, <string-name><surname>Vogels</surname>, <given-names>C. B.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>). <article-title>Sars-cov-2 viral dynamics in acute infections</article-title>. <source>MedRxiv</source>, pages <fpage>2020</fpage>–<lpage>10</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Lei</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Dong</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Xiao</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Tian</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ren</surname>, <given-names>L.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>). <article-title>Activation and evasion of type i interferon responses by sars-cov-2</article-title>. <source>Nature communications</source>, <volume>11</volume>(<issue>1</issue>):<fpage>3810</fpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J.-H.</given-names></string-name>, <string-name><surname>Parker</surname>, <given-names>Z. M.</given-names></string-name>, <string-name><surname>Acharya</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Chiang</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>van Gent</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Riedl</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Davis-Gardner</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Wies</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Chiang</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>). <article-title>Isg15-dependent activation of the sensor mda5 is antagonized by the sars-cov-2 papain-like protease to evade host innate immunity</article-title>. <source>Nature microbiology</source>, <volume>6</volume>(<issue>4</issue>):<fpage>467</fpage>–<lpage>478</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Loske</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Röhmel</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lukassen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Stricker</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Magalhães</surname>, <given-names>V. G.</given-names></string-name>, <string-name><surname>Liebig</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Chua</surname>, <given-names>R. L.</given-names></string-name>, <string-name><surname>Thürmann</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Messingschlager</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Seegebarth</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2022</year>). <article-title>Pre-activated antiviral innate immunity in the upper airways controls early sars-cov-2 infection in children</article-title>. <source>Nature biotechnology</source>, <volume>40</volume>(<issue>3</issue>):<fpage>319</fpage>–<lpage>324</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>McNab</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Mayer-Barber</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Sher</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wack</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>O’garra</surname>, <given-names>A.</given-names></string-name> (<year>2015</year>). <article-title>Type i interferons in infectious disease</article-title>. <source>Nature Reviews Immunology</source>, <volume>15</volume>(<issue>2</issue>):<fpage>87</fpage>–<lpage>103</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Michael Lavigne</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Russell</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sherry</surname>, <given-names>B.</given-names></string-name>, and <string-name><surname>Ke</surname>, <given-names>R.</given-names></string-name> (<year>2021</year>). <article-title>Autocrine and paracrine interferon signalling as ‘ring vaccination’and ‘contact tracing’strategies to suppress virus infection in a host</article-title>. <source>Proceedings of the Royal Society B</source>, <volume>288</volume>(<issue>1945</issue>):<fpage>20203002</fpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="other"><string-name><surname>Minkoff</surname>, <given-names>J. M.</given-names></string-name> and <string-name><surname>tenOever</surname>, <given-names>B.</given-names></string-name> (<year>2023</year>). <article-title>Innate immune evasion strategies of sars-cov-2</article-title>. <source>Nature Reviews Microbiology</source>, pages <fpage>1</fpage>–<lpage>17</lpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Mohamadzadeh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Schmaljohn</surname>, <given-names>A. L.</given-names></string-name> (<year>2007</year>). <article-title>How ebola and marburg viruses battle the immune system</article-title>. <source>Nature Reviews Immunology</source>, <volume>7</volume>(<issue>7</issue>):<fpage>556</fpage>–<lpage>567</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Nielsen</surname>, <given-names>B. F.</given-names></string-name>, <string-name><surname>Simonsen</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Sneppen</surname>, <given-names>K.</given-names></string-name> (<year>2021</year>). <article-title>Covid-19 superspreading suggests mitigation by social network modulation</article-title>. <source>Physical Review Letters</source>, <volume>126</volume>(<issue>11</issue>):<fpage>118301</fpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Polack</surname>, <given-names>F. P.</given-names></string-name>, <string-name><surname>Thomas</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Kitchin</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Absalon</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Gurtman</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lockhart</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Perez</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Pérez Marc</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Moreira</surname>, <given-names>E. D.</given-names></string-name>, <string-name><surname>Zerbini</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>). <article-title>Safety and efficacy of the bnt162b2 mrna covid-19 vaccine</article-title>. <source>New England journal of medicine</source>, <volume>383</volume>(<issue>27</issue>):<fpage>2603</fpage>–<lpage>2615</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Ravindra</surname>, <given-names>N. G.</given-names></string-name>, <string-name><surname>Alfajaro</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Gasque</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Huston</surname>, <given-names>N. C.</given-names></string-name>, <string-name><surname>Wan</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Szigeti-Buck</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Yasumoto</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Greaney</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Habet</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Chow</surname>, <given-names>R. D.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>). <article-title>Single-cell longitudinal analysis of sars-cov-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes</article-title>. <source>PLoS biology</source>, <volume>19</volume>(<issue>3</issue>):<fpage>e3001143</fpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Sanceau</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sondermeyer</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Beranger</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Falcoff</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Vaquero</surname>, <given-names>C.</given-names></string-name> (<year>1987</year>). <article-title>Intracellular human gamma-interferon triggers an antiviral state in transformed murine l cells</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>84</volume>(<issue>9</issue>):<fpage>2906</fpage>–<lpage>2910</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Schaller</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Sharma</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Dupee</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Nguyen</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Urueña</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Smolchek</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Loeb</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Machuca</surname>, <given-names>T. N.</given-names></string-name>, <string-name><surname>Lednicky</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Odde</surname>, <given-names>D. J.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>). <article-title>Ex vivo sars-cov-2 infection of human lung reveals heterogeneous host defense and therapeutic responses</article-title>. <source>JCI insight</source>, <volume>6</volume>(<issue>18</issue>).</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Segredo-Otero</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Sanjuán</surname>, <given-names>R.</given-names></string-name> (<year>2020</year>). <article-title>The role of spatial structure in the evolution of viral innate immunity evasion: A diffusion-reaction cellular automaton model</article-title>. <source>PLoS Computational Biology</source>, <volume>16</volume>(<issue>2</issue>):<fpage>e1007656</fpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Sette</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Crotty</surname>, <given-names>S.</given-names></string-name> (<year>2021</year>). <article-title>Adaptive immunity to sars-cov-2 and covid-19</article-title>. <source>Cell</source>, <volume>184</volume>(<issue>4</issue>):<fpage>861</fpage>–<lpage>880</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Stanifer</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Kee</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Cortese</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zumaran</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Triana</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Mukenhirn</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kraeusslich</surname>, <given-names>H.-G.</given-names></string-name>, <string-name><surname>Alexandrov</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bartenschlager</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Boulant</surname>, <given-names>S.</given-names></string-name> (<year>2020</year>). <article-title>Critical role of type iii interferon in controlling sars-cov-2 infection in human intestinal epithelial cells</article-title>. <source>Cell reports</source>, <volume>32</volume>(<issue>1</issue>):<fpage>107863</fpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="book"><string-name><surname>Stauffer</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Aharony</surname>, <given-names>A.</given-names></string-name> (<year>2018</year>). <source>Introduction to percolation theory</source>. <publisher-name>CRC press</publisher-name>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Tabata</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Imai</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kawano</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ikeda</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kodama</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Miyoshi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Obinata</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Mimura</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kodera</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kitagaki</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>). <article-title>Clinical characteristics of covid-19 in 104 people with sars-cov-2 infection on the diamond princess cruise ship: a retrospective analysis</article-title>. <source>The Lancet Infectious Diseases</source>, <volume>20</volume>(<issue>9</issue>):<fpage>1043</fpage>–<lpage>1050</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Tesfaigzi</surname>, <given-names>Y.</given-names></string-name> (<year>2006</year>). <article-title>Roles of apoptosis in airway epithelia</article-title>. <source>American journal of respiratory cell and molecular biology</source>, <volume>34</volume>(<issue>5</issue>):<fpage>537</fpage>–<lpage>547</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hao</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pan</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Lei</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Zou</surname>, <given-names>X.</given-names></string-name> (<year>2021</year>). <article-title>Data-driven multi-scale mathematical modeling of sars-cov-2 infection reveals heterogeneity among covid-19 patients</article-title>. <source>PLoS Computational Biology</source>, <volume>17</volume>(<issue>11</issue>):<fpage>e1009587</fpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Wen</surname>, <given-names>L.-P.</given-names></string-name>, <string-name><surname>Madani</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Fahrni</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Duncan</surname>, <given-names>S. R.</given-names></string-name>, and <string-name><surname>Rosen</surname>, <given-names>G. D.</given-names></string-name> (<year>1997</year>). <article-title>Dexamethasone inhibits lung epithelial cell apoptosis induced by ifn-γ and fas</article-title>. <source>American Journal of Physiology-Lung Cellular and Molecular Physiology</source>, <volume>273</volume>(<issue>5</issue>):<fpage>L921</fpage>–<lpage>L929</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Saldi</surname>, <given-names>T. K.</given-names></string-name>, <string-name><surname>Gonzales</surname>, <given-names>P. K.</given-names></string-name>, <string-name><surname>Lasda</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Decker</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Tat</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Fink</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Hager</surname>, <given-names>C. R.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Ozeroff</surname>, <given-names>C. D.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>). <article-title>Just 2% of sars-cov-2-positive individuals carry 90% of the virus circulating in communities</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>118</volume>(<issue>21</issue>):<fpage>e2104547118</fpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Yin</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Riva</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Pu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Martin-Sancho</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Kanamune</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Yamamoto</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Sakai</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Gotoh</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Miorin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>De Jesus</surname>, <given-names>P. D.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>). <article-title>Mda5 governs the innate immune response to sars-cov-2 in lung epithelial cells</article-title>. <source>Cell reports</source>, <volume>34</volume>(<issue>2</issue>).</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.94056.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ispolatov</surname>
<given-names>Yaroslav</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Santiago Chile</institution>
</institution-wrap>
<city>Santiago</city>
<country>Chile</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study presents a cellular automaton model to study the dynamics of virus-induced signalling and innate host defense against viruses such as SARS-CoV-2 in epithelial tissue. The data presented are <bold>convincing</bold> and represent a <bold>valuable</bold> contribution that would be of interest to researchers studying the dynamics of viral propogation. The significance of the study might be further elevated with more details on the reduction of expression data to the model rules discussed.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.94056.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
The manuscript ``Self-inhibiting percolation and viral spreading in epithelial tissue' describes a model based on 5-state cellular automata of development of an infection. The model is motivated and qualitatively justified by time-resolved measurements of expression levels of viral, interferon-producing, and antiviral genes. The model is set up in such a way that the crucial difference in outcomes (infection spreading vs. confinement) depends on the initial fraction of special virus-sensing cells. Those cells (denoted as 'type a') cannot be infected and do not support the propagation of infection, but rather inhibit it in a somewhat autocatalytic way. Presumably, such feedback makes the transition between two outcomes very sharp: a minor variation in concentration of ``a' cells results in qualitative change from one outcome to another. As in any percolation-like system, the transition between propagation and inhibition of infection goes through a critical state with all its attributes. A power-law distribution of the cluster size (corresponding to the fraction of infected cells) with a fairly universal exponent and a cutoff at the upper limit of this distribution.</p>
<p>Strengths:</p>
<p>
The proposed model suggests an explanation for the apparent diversity of outcomes of viral infections such as COVID.</p>
<p>Weaknesses:</p>
<p>
Those are not real points of weakness, though I think addressing them would substantially improve the manuscript.</p>
<p>The key point in the manuscript is the reduction of actual biochemical processes to the NOVAa rules. I think more could be said about it, be it referring to a set of well-known connections between expression states of cells and their reaction to infection or justifying it as an educated guess.</p>
<p>Another aspect where the manuscript could be improved would be to look a little beyond the strange and 'not-so-relevant for a biomedical audience' focus on the percolation critical state. While the presented calculation of the precise percolation threshold and the critical exponent confirm the numerical skills of the authors, the probability that an actual infected tissue is right at the threshold is negligible. So in addition to the critical properties, it would be interesting to learn about the system not exactly at the threshold: For example, how the speed of propagation of infection depends on subcritical p_a and what is the cluster size distribution for supercritical p_a.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.94056.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Xu et al. introduce a cellular automaton model to investigate the spatiotemporal spreading of viral infection. In this study, the author first analyzes the single-cell RNA sequencing data from experiments and identifies four clusters of cells at 48 hours post-viral infection, including susceptible cells (O), infected cells (V), IFN-secreting cells (N), and antiviral cells (A). Next, a cellular automaton model (NOVAa model) is introduced by assuming the existence of a transient pre-antiviral state (a). The model consists of an LxL lattice; each site represents one cell. The cells change their state following the rules depending on the interaction of neighboring cells. The model introduces a key parameter, p_a, representing the fraction of pre-antiviral state cells. Cell apoptosis is omitted in the model. Model simulations show a threshold-like behavior of the final attack rate of the virus when p_a changes continuously. There is a critical value p_c, so that when p_a &lt; p_c, infections typically spread to the entire system, while at a higher p_a &gt; p_c, the propagation of the infected state is inhibited. Moreover, the radius R that quantifies the diffusion range of N cells may affect the critical value p_c; a larger R yields a smaller value of the critical value p_c. The structure of clusters is different for different values of R; greater R leads to a different microscopic structure with fewer A and N cells in the final state. Compared with the single-cell RNA seq data, which implies a low fraction of IFN-positive cells - around 1.7% - the model simulation suggests R=5. The authors also explored a simplified version of the model, the OVA model, with only three states. The OVA model also has an outbreak size. The OVA model shows dynamics similar to the NOVAa model. However, the change in microstructure as a function of the IFN range R observed in the NOVAa model is not observed in the OVA model.</p>
<p>Data and model simulation mainly support the conclusions of this paper, but some weaknesses should be considered or clarified.</p>
<p>1. In the automaton model, the authors introduce a parameter p_a, representing the fraction of pre-antiviral state cells. The authors wrote: ``The parameter p_a can also be understood as the probability that an O cell will switch to the N or A state when exposed to the virus of IFNs, respectively.' Nevertheless, biologically, the fraction of pre-antiviral state cells does not mean the same value as the probability that an O cell switches to the N or A state. Moreover, in the numerical scheme, the cell state changes according to the deterministic role N(O)=a and N(a)=A. Hence, the probability p_a did not apply to the model simulation. It may need to clarify the exact meaning of the parameter p_a.</p>
<p>2. The current model is deterministic. However, biologically, considering the probabilistic model may be more realistic. Are the results valid when the probability update strategy is considered? By the probability model, the cells change their state randomly to the state of the neighbor cells. The probability of cell state changes may be relevant for the threshold of p_a. It is interesting to know how the random response of cells may affect the main results and the critical value of p_a.</p>
<p>3. Figure 2 shows a critical value p_c = 27.8% following a simulation on a lattice with dimension L = 1000. However, it is unclear if dimension changes may affect the critical value.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.94056.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
This study considers how to model distinct host cell states that correspond to different stages of a viral infection: from naïve and susceptible cells to infected cells and a minority of important interferon-secreting cells that are the first line of defense against viral spread. The study first considers the distinct host cell states by analyzing previously published single-cell RNAseq data. Then an agent-based model on a square lattice is used to probe the dependence of the system on various parameters. Finally, a simplified version of the model is explored, and shown to have some similarity with the more complex model, yet lacks the dependence on the interferon range. By exploring these models one gains an intuitive understanding of the system, and the model may be used to generate hypotheses that could be tested experimentally, telling us &quot;when to be surprised&quot; if the biological system deviates from the model predictions.</p>
<p>Strengths:</p>
<p>
- Clear presentation of the experimental findings and a clear logical progression from these experimental findings to the modeling.</p>
<p>
- The modeling results are easy to understand, revealing interesting behavior and percolation-like features.</p>
<p>
- The scaling results presented span several decades and are therefore compelling.</p>
<p>
- The results presented suggest several interesting directions for theoretical follow-up work, as well as possible experiments to probe the system (e.g. by stimulating or blocking IFN secretion).</p>
<p>Weaknesses:</p>
<p>
- Since the &quot;range&quot; of IFN is an important parameter, it makes sense to consider lattice geometries other than the square lattice, which is somewhat pathological. Perhaps a hexagonal lattice would generalize better.</p>
<p>- Tissues are typically three-dimensional, not two-dimensional. (Epithelium is an exception). It would be interesting to see how the modeling translates to the three-dimensional case. Percolation transitions are known to be very sensitive to the dimensionality of the system.</p>
<p>- The fixed time-step of the agent-based modeling may introduce biases. I would consider simulating the system with Gillespie dynamics where the reaction rates depend on the ambient system parameters.</p>
<p>- Single-cell RNAseq data typically involves data imputation due to the high sparsity of the measured gene expression. More information could be provided on this crucial data processing step since it may significantly alter the experimental findings.</p>
<p>Justification of claims and conclusions:</p>
<p>
The claims and conclusions are well justified.</p>
</body>
</sub-article>
</article>